← All Nanoviricides, INC filings

Nanoviricides, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
NNVC
Nanoviricides, INC
DEF: NanoViricides Sets Annual Meeting Date, Seeks Director Re-election
NanoViricides, Inc. has issued its proxy statement for the upcoming Annual Meeting of Stockholders, scheduled for November 21, 2026, detailing proposals for director elections and auditor ratification.
AMEX
NNVC
Nanoviricides, INC
DEF 14A: NanoViricides Sets 2025 Annual Meeting Agenda
NanoViricides, Inc. announced its 2025 Annual Meeting of Stockholders to address director re-election, executive compensation, auditor ratification, and provided updates on related party transactions and clinical trials.
AMEX
NNVC
Nanoviricides, INC
DEF 14A: NanoViricides Seeks Stockholder Approval for Director Elections, Executive Compensation, and Auditor Ratification at Upcoming Annual Meeting
NanoViricides, Inc. is holding its annual meeting on December 7, 2024, to vote on director elections, executive compensation, and the ratification of its independent auditor.